Facet Life Sciences Announces Partnership with Nucleus RadioPharma as Official Regulatory Partner News Facet Life Sciences Announces Partnership with Nucleus RadioPharma as Official Regulatory Partner
Ask the right questions at every stage to keep your radiopharmaceutical on track Industry Insights Ask the right questions at every stage to keep your radiopharmaceutical on track
How to prepare your radiotherapeutic for success at scale Industry Insights How to prepare your radiotherapeutic for success at scale
Five key considerations for the administration of your radiopharmaceutical therapy Industry Insights Five key considerations for the administration of your radiopharmaceutical therapy
Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves News Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves
Key differences between 21 CFR 211 and 21 CFR 212 for radiopharmaceuticals Industry Insights Key differences between 21 CFR 211 and 21 CFR 212 for radiopharmaceuticals
CMS’s CY2025 radiopharma ruling: What you need to know Industry Insights CMS’s CY2025 radiopharma ruling: What you need to know
Progress and predictions for radiopharmaceuticals in 2025 Industry Insights Progress and predictions for radiopharmaceuticals in 2025
2024 recap: New possibilities in radiopharmaceuticals from clinical trials to early-stage treatment Industry Insights 2024 recap: New possibilities in radiopharmaceuticals from clinical trials to early-stage treatment
AstraZeneca-backed CDMO Nucleus RadioPharma to boost commercial capacity News AstraZeneca-backed CDMO Nucleus RadioPharma to boost commercial capacity
